RA PHARMACEUTICALS, INC. General and Administrative Expense
RA PHARMACEUTICALS, INC. reported General and Administrative Expense of $27.34 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2020-02-27
- RA PHARMACEUTICALS, INC. general and administrative expense for the quarter ending 2019-12-31 was $11.63M, a 205.76% increase year-over-year.
- RA PHARMACEUTICALS, INC. general and administrative expense for the quarter ending 2019-09-30 was $5.97M, a 70.43% increase year-over-year.
- RA PHARMACEUTICALS, INC. general and administrative expense for the quarter ending 2019-06-30 was $4.93M, a 29.10% increase year-over-year.
- RA PHARMACEUTICALS, INC. general and administrative expense for the quarter ending 2019-03-31 was $4.81M, a 45.14% increase year-over-year.
- RA PHARMACEUTICALS, INC. general and administrative expense for fiscal 2019 was $27.34M, a 89.33% increase from fiscal 2018.
- RA PHARMACEUTICALS, INC. general and administrative expense for fiscal 2018 was $14.44M, a 47.67% increase from fiscal 2017.
- RA PHARMACEUTICALS, INC. general and administrative expense for fiscal 2017 was $9.78M, a 94.63% increase from fiscal 2016.
- RA PHARMACEUTICALS, INC. general and administrative expense for fiscal 2016 was $5.02M, a 124.99% increase from fiscal 2015.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2019-12-31 | $11.63M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $17.60M derived: sum of 2 quarters · filed 2020-02-27 | $22.53M derived: sum of 3 quarters · filed 2020-02-27 | $27.34M 10-K · filed 2020-02-27 |
| 2019-09-30 | $5.97M 10-Q · filed 2019-11-07 | $10.90M derived: sum of 2 quarters · filed 2019-11-07 | $15.71M 10-Q · filed 2019-11-07 | $19.51M derived: sum of 4 quarters · filed 2020-02-27 |
| 2019-06-30 | $4.93M 10-Q · filed 2019-08-07 | $9.74M 10-Q · filed 2019-08-07 | $13.54M derived: sum of 3 quarters · filed 2020-02-27 | $17.05M derived: sum of 4 quarters · filed 2020-02-27 |
| 2019-03-31 | $4.81M 10-Q · filed 2019-05-09 | $8.61M derived: sum of 2 quarters · filed 2020-02-27 | $12.11M derived: sum of 3 quarters · filed 2020-02-27 | $15.93M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-12-31 | $3.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $7.31M derived: sum of 2 quarters · filed 2020-02-27 | $11.13M derived: sum of 3 quarters · filed 2020-02-27 | $14.44M 10-K · filed 2020-02-27 |
| 2018-09-30 | $3.50M 10-Q · filed 2019-11-07 | $7.33M derived: sum of 2 quarters · filed 2019-11-07 | $10.64M 10-Q · filed 2019-11-07 | $13.31M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $3.82M 10-Q · filed 2019-08-07 | $7.13M 10-Q · filed 2019-08-07 | $9.81M derived: sum of 3 quarters · filed 2019-08-07 | $12.09M derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | $3.31M 10-Q · filed 2019-05-09 | $5.99M derived: sum of 2 quarters · filed 2019-05-09 | $8.27M derived: sum of 3 quarters · filed 2019-05-09 | $10.62M derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $2.68M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $4.96M derived: sum of 2 quarters · filed 2019-03-07 | $7.31M derived: sum of 3 quarters · filed 2019-03-07 | $9.78M 10-K · filed 2019-03-07 |
| 2017-09-30 | $2.28M 10-Q · filed 2018-11-07 | $4.63M derived: sum of 2 quarters · filed 2018-11-07 | $7.10M 10-Q · filed 2018-11-07 | $8.71M derived: sum of 4 quarters · filed 2018-11-07 |
| 2017-06-30 | $2.35M 10-Q · filed 2018-08-08 | $4.82M 10-Q · filed 2018-08-08 | $6.42M derived: sum of 3 quarters · filed 2018-08-08 | $7.46M derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-03-31 | $2.47M 10-Q · filed 2018-05-09 | $4.08M derived: sum of 2 quarters · filed 2018-05-09 | $5.12M derived: sum of 3 quarters · filed 2018-05-09 | $6.20M derived: sum of 4 quarters · filed 2018-05-09 |
| 2016-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $2.65M derived: sum of 2 quarters · filed 2018-03-14 | $3.73M derived: sum of 3 quarters · filed 2018-03-14 | $5.02M 10-K · filed 2018-03-14 |
| 2016-09-30 | $1.04M 10-Q · filed 2017-11-09 | $2.13M derived: sum of 2 quarters · filed 2017-11-09 | $3.42M 10-Q · filed 2017-11-09 | $4.10M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | $1.08M 10-Q · filed 2017-08-09 | $2.38M 10-Q · filed 2017-08-09 | $3.06M derived: sum of 3 quarters · filed 2018-03-14 | $3.60M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | $1.29M 10-Q · filed 2017-05-11 | $1.98M derived: sum of 2 quarters · filed 2018-03-14 | $2.51M derived: sum of 3 quarters · filed 2018-03-14 | |
| 2015-12-31 | $684.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $1.22M derived: sum of 2 quarters · filed 2018-03-14 | $2.23M 10-K · filed 2018-03-14 | |
| 2015-09-30 | $539.00K 10-Q · filed 2016-11-29 | $1.55M 10-Q · filed 2016-11-29 | ||
| 2014-12-31 | $1.92M 10-K · filed 2017-03-06 |